106 related articles for article (PubMed ID: 2894547)
21. Bromocriptine in the treatment of advanced breast cancer.
Barrett A; Morgan L; Raggatt PR; Hobbs JR
Clin Oncol; 1976 Dec; 2(4):373-7. PubMed ID: 1037393
[No Abstract] [Full Text] [Related]
22. No effect of bromocriptine in acromegaly: a controlled trial.
Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
[TBL] [Abstract][Full Text] [Related]
23. Effect of mastectomy versus mastectomy plus adjuvant ovariectomy on prolactin response to TRH in breast cancer.
Ayala D; Lissoni P; Archili C; Barni S; Roveda G; Giacomelli M; Bissi A
J Biol Regul Homeost Agents; 1990; 4(4):150-2. PubMed ID: 2128988
[TBL] [Abstract][Full Text] [Related]
24. Bromocriptine and premenstrual tension: a clinical and hormonal study.
Andersch B; Hahn L
Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
[TBL] [Abstract][Full Text] [Related]
25. Use of bromocriptine in unexplained infertility.
McBain JC; Pepperell RJ
Clin Reprod Fertil; 1982 Jun; 1(2):145-50. PubMed ID: 6764750
[TBL] [Abstract][Full Text] [Related]
26. European multicentre trial of bromocriptine in cyclical mastalgia.
Mansel RE; Dogliotti L
Lancet; 1990 Jan; 335(8683):190-3. PubMed ID: 1967667
[TBL] [Abstract][Full Text] [Related]
27. Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.
Lissoni P; Barni S; Cazzaniga M; Ardizzoia A; Rovelli F; Tancini G; Brivio F; Frigerio F
Oncology; 1995; 52(6):439-42. PubMed ID: 7478427
[TBL] [Abstract][Full Text] [Related]
28. A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour.
Messina G; Lissoni P; Brivio F; Rovelli F; Fumagalli L; Bartolacelli E; Mazza U; Colombo E; Bertoglio A
In Vivo; 2008; 22(6):845-8. PubMed ID: 19181018
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
Powles TJ; Hickish TF; Makris A; Ashley SE; O'Brien ME; Tidy VA; Casey S; Nash AG; Sacks N; Cosgrove D
J Clin Oncol; 1995 Mar; 13(3):547-52. PubMed ID: 7884414
[TBL] [Abstract][Full Text] [Related]
30. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
31. HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.
Lissoni P; Messina G; Rovelli F; Brivio F; Fumagalli L; Villa S; Bartolacelli E
In Vivo; 2009; 23(6):987-9. PubMed ID: 20023245
[TBL] [Abstract][Full Text] [Related]
32. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
Galvan G; Frick J; Irnberger T
Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
[TBL] [Abstract][Full Text] [Related]
33. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia.
Nazli K; Syed S; Mahmood MR; Ansari F
Br J Clin Pract; 1989 Sep; 43(9):322-7. PubMed ID: 2695151
[TBL] [Abstract][Full Text] [Related]
34. Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.
Ludwig Breast Cancer Study Group
N Engl J Med; 1988 Sep; 319(11):677-83. PubMed ID: 2901037
[TBL] [Abstract][Full Text] [Related]
35. A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
Wijsman JH; Cornelisse CJ; Keijzer R; van de Velde CJ; van Dierendonck JH
Br J Cancer; 1991 Sep; 64(3):463-8. PubMed ID: 1911185
[TBL] [Abstract][Full Text] [Related]
36. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
37. Extrasellar prolactinomas: successful management of 24 patients using bromocriptine.
Sieck JO; Niles NL; Jinkins JR; Al-Mefty O; el-Akkad S; Woodhouse N
Horm Res; 1986; 23(3):167-76. PubMed ID: 3949288
[TBL] [Abstract][Full Text] [Related]
38. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
39. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: cochrane review.
Hind D; Wyld L; Reed MW
Br J Cancer; 2007 Apr; 96(7):1025-9. PubMed ID: 17285133
[TBL] [Abstract][Full Text] [Related]
40. [Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].
Mussa A; Dogliotti L; Di Carlo F
Minerva Med; 1977 Jun; 68(32):2233-44. PubMed ID: 577604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
